ARIX — Arix Bioscience Share News
0.000.00%
Last trade - 00:00- £183.80m
- £82.85m
- £0.11m
Harpoon Therapeutics rises on collaboration with AbbVie
Brief: Woodford Investment Management Discloses Less Than 5% Stake In Arix Bioscience As At Oct 15- Filing
Brief: Arix Bioscience Announces Departure Of CFO James Rawlingson
Brief: Arix Bioscience Says Amplyx Unveils Expanded Pipeline And Phase 2 Data
Brief: Arix Bioscience Posts HY Loss Before Tax £44.8 Mln
Brief: Woodford Investment Management Cuts Stake In Arix Bioscience To 21.89% - Filing
Brief: Arix Bioscience Says Autolus Prices Public Offering At $24.00 Per ADS
Brief: Arix Bioscience Says Aura Completes $40 Mln Series D Financing
UK Stocks-Factors to watch on March 28 (updated)
Europe Research Roundup: EasyJet, Fevertree Drinks, Kws Saat
UK Stocks-Factors to watch on March 28
Brief: Arix Bioscience To Invest $15 Mln For 10 Pct Stake On Fully Diluted Basis In Imara
Brief: Reg-Arix Bioscience Appoints Joe Anderson As CEO
Brief: Arix Bioscience's Joe Anderson Has Been Reappointed As Chief Executive Officer
Brief: Arix Bioscience PLC Harpoon Closes Initial Public Offering
Europe Research Roundup: Bodycote, Bunzl, Intu Properties
Brief: Arix Invests $8 Million In Harpoon Therapeutics' Financing
Brief: Arix Bioscience Says Aura Reported Positive Phase 1B/2 Clinical Data For AU-011
Brief: Arix Bioscience Announces Pricing Of IPO At $10.00 Per Share